A Study to Assess the Safety, Tolerability, and Pharmacokinetics of AZD9550 Following Single Ascending Dose Administration to Healthy Participants
Clinical trial NCT05848440 · COMPLETED
Trial details
- NCT number
- NCT05848440
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-02
- Primary completion
- 2023-11-13
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.